LOX and colorectal carcinoma: Genetic variations in the LOX pathway have also been shown to influence CRC and CRA risk [12], and cytochrome P450 4A/4F CYP4A/4F [the CYP450 enzyme that produces 20-hydroxyeicosatetraenoic acid (20-HETE)] is elevated in multiple cancers, including CRC [13].